ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Clinical trials for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) explained in plain language.
Never miss a new study
Get alerted when new ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) trials appear
Sign up with your email to follow new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug TISA-818 shows promise for ARDS patients in early trial
Disease control CompletedThis study tested an experimental drug called TISA-818-Inj in 57 adults with acute respiratory distress syndrome (ARDS), a severe lung condition that makes breathing very difficult. The goal was to see if the drug is safe and whether it can help patients spend fewer days on breat…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Phase: PHASE2 • Sponsor: EnliTISA (Shanghai) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
Chest x-rays miss ARDS in many ICU patients, study finds
Diagnosis CompletedThis study looked at 277 ICU patients on breathing machines to see how well chest X-rays (read by intensive care doctors) agree with CT scans (read by radiologists) for diagnosing acute respiratory distress syndrome (ARDS). The results showed that X-rays often do not detect ARDS …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Sponsor: Poitiers University Hospital • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC
-
Study: first ICU diagnosis may reveal hidden death risk
Knowledge-focused CompletedThis study reviewed records of 1248 adults admitted to an intensive care unit (ICU) in 2025. Researchers wanted to see if the reason for admission (like sepsis or breathing failure) could predict who dies in the ICU, beyond what standard severity scores show. The goal is to impro…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Sponsor: Ataturk University • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
Massive study reveals hidden toll of ICU on ARDS survivors
Knowledge-focused CompletedThis study looked at health insurance records of over 640,000 people in the US who had acute respiratory distress syndrome (ARDS) and were treated in the ICU. Researchers wanted to find out what new health problems—physical, mental, or emotional—people face after leaving the ICU,…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC